Logo
  • Search
  • Subscribe
  • Login
  • News
  • Business
  • Opinion
  • Archive
  • Jobs Market
  • About DT
  • Contact
  • Search
  • Subscribe
  • Login

Indian-made pneumonia vaccine is set to break Big Pharma’s hold on Gavi funds

News April 22, 2019

By the end of the year, a new pneumonia vaccine produced by Serum Institute of India is set to enter the market at a much lower price than Gavi currently pays. Key vaccine actors call this a “game changer” that could reduce prices and save children’s lives.

baby vaccine Photo Rumi Consultancy World Bank.jpg

If you are new to Development Today and would like to continue reading this article, send us a mail at subscribers@devtoday.no, including your name, title, organisation, and email contact, and you will receive a free Guest Pass, along with weekly updates.

Log in or subscribe

Tags:

AMC vaccine deal Global health
  • Home
  • Archive
  • 2019
  • DT 3 / 2019
  • Indian-made pneumonia vaccine is set to break Big Pharma’s hold on Gavi funds

Development Today AS
Box 140
1371 Asker
Norway
Tel: +47 66902660
E-mail: devtoday@devtoday.no

  • News
  • Business
  • Opinion
  • Archive
  • About DT
  • Privacy and Cookie policy
  • Contact
  • Log in
  • Subscribe

Design and development: Snapper Net Solutions